← SynDRA
EBPC
SynDRA canonical compound SYN0062882 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | AKR1B1 |
|---|
| Mechanism of action | Aldose reductase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- Aldose reductase inhibitor
Cross-references
Synonyms
- Ethyl 1-benzyl-4,5-dioxopyrrolidine-3-carboxylate
- MFCD00098219
- 1-Benzyl-4,5-dioxo-pyrrolidine-3-carboxylic acid ethyl ester
- MLS002637507
- Ethyl 1-benzyl-4,5-dioxo-pyrrolidine-3-carboxylate
- ethyl 4,5-dioxo-1-benzylazolidine-3-carboxylate
- NSC334
- SCHEMBL1832087
- CHEBI:91978
- NSC-334
- FQMSSTZJKSWSMP-UHFFFAOYSA-N
- 1-BENZYL-4, ETHYL ESTER
- HMS3094F19
- BDBM50009832
- CS1056
- SBB079333
- AKOS005265245
- AS-5260
- AC-31242
- AS-46488
- DA-34674
- PD062910
- SMR001547045
- CS-0299083
- ST51079240
- EN300-110978
- Ethyl 1-benzyl-4,5-dioxo-3-pyrrolidinecarboxylate
- ethyl1-benzyl-4,5-dioxopyrrolidine-3-carboxylate
- BRD-A96485169-001-02-8
- BRD-A96485169-001-05-1
- BRD-A96485169-001-14-3
- 1-BENZYL-4,5-DIOXO-3-PYRROLIDINECARBOXYLIC ACID, ETHYL ESTER
- 4,5-dioxo-1-(phenylmethyl)-3-pyrrolidinecarboxylic acid ethyl ester
Look up EBPC in the interactive SynDRA portal →